SPIE awards OCT pioneer James Fujimoto with Britton Chance Biomedical Optics Award
Optical coherence tomography (OCT) pioneer James Fujimoto, Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT), has been awarded the SPIE Britton Chance Biomedical Optics Award.
Optical coherence tomography (OCT) pioneer James Fujimoto, Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT; Cambridge, MA), has been awarded the SPIE Britton Chance Biomedical Optics Award. The annual award honors contributions to optical methods and devices that have significant promise to accelerate or have already facilitated new discoveries in biology or medicine; this year's award recognizes Fujimoto's trailblazing research in OCT and its development as a clinical tool.
“Jim’s innovation, scholarly activities, professional service, entrepreneurial efforts, and impact on the field of biomedical optics typifies the spirit of this award, and reflects the seminal changes that Britton Chance made during his lifetime,” says Stephen A. Boppart, University of Illinois at Urbana-Champaign. “Few researchers in the world today have had such a profound impact as a result of their technological work that has literally changed our field, changed the way we practice medicine, and directly improved the lives of perhaps hundreds of thousands of patients (considering ophthalmology and cardiology).”
Fujimoto, a SPIE Fellow, will receive his award on February 2 during the SPIE Biomedical Optics Symposium's (BiOS') Hot Topics session at SPIE Photonics West, to take place February 2–9 in San Francisco, CA.
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Subscribe now to BioOptics World magazine; it's free!